An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2025 Jan-.
Top results in this bookTable of Contents
NIEHS Technical Report on the Reproductive, Developmental, and General Toxicity Study of 3’-Azido-3’-deoxythymidine (AZT), Trimethoprim (TMP)/Sulfamethoxazole (SMX), and Folinic Acid Combinations Administered by Gavage to Swiss (CD-1®) Mice [Internet].
Rao GN, Cirvello JD, Rogers TR, et al.
Research Triangle Park (NC): National Institute of Environmental Health Sciences; 1998 Dec. (Toxicity Report, No. 2.)
Holland-Frei Cancer Medicine. 6th edition.
Kufe DW, Pollock RE, Weichselbaum RR, et al., editors.
Hamilton (ON): BC Decker; 2003.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Nivolumab (Opdivo): CADTH Reimbursement Review: Therapeutic area: Gastric, gastroesophageal junction, or esophageal adenocarcinoma [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jul.
The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation.
Huxley N, Crathorne L, Varley-Campbell J, et al.
Southampton (UK): NIHR Journals Library; 2017 Jun. (Health Technology Assessment, No. 21.38.)
Pembrolizumab (Keytruda): In combination with fluoropyrimidine and platinum–containing chemotherapy, is indicated for the first-line treatment of adult patients with locally advanced, unresectable, or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma: Reimbursement Review [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2025 Jan.
Pembrolizumab (Keytruda): CADTH Reimbursement Review: Therapeutic area: Esophageal carcinoma, gastroesophageal junction adenocarcinoma [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Feb.
Pembrolizumab (Keytruda): Therapeutic area: Gastric or gastroesophageal junction adenocarcinoma: Reimbursement Review [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Nov.
Pancreatic cancer in adults: diagnosis and management.
National Guideline Alliance (UK).
London: National Institute for Health and Care Excellence (NICE); 2018 Feb. (NICE Guideline, No. 85.)
Nelarabine (Atriance): CADTH Reimbursement Review: Therapeutic area: T-cell acute lymphoblastic leukemia [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Nov.
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2025.
Nivolumab (Opdivo): CADTH Reimbursement Review: Therapeutic area: Esophageal or gastroesophageal junction cancer [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Mar.
Fluorouracil plasma monitoring: systematic review and economic evaluation of the My5-FU assay for guiding dose adjustment in patients receiving fluorouracil chemotherapy by continuous infusion.
Freeman K, Connock M, Cummins E, et al.
Southampton (UK): NIHR Journals Library; 2015 Nov. (Health Technology Assessment, No. 19.91.)
DNA Mismatch Repair Deficiency Tumour Testing for Patients With Colorectal Cancer: A Health Technology Assessment [Internet].
Assasi N, Blackhouse G, Campbell K, et al.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Aug. (CADTH Optimal Use Report, No. 5.3b.)
Pemigatinib (Pemazyre): CADTH Reimbursement Review: Therapeutic area: Cholangiocarcinoma [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].
Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.
Durvalumab (Imfinzi): CADTH Reimbursement Review: Therapeutic area: Biliary tract cancer [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Apr.
Diagnosis and Management of Metastatic Malignant Disease of Unknown Primary Origin.
Cardiff (UK): National Collaborating Centre for Cancer (UK); 2010 Jul. (NICE Clinical Guidelines, No. 104.)
Trifluridine-Tipiracil (Lonsurf): CADTH Reimbursement Review: Therapeutic area: Metastatic colorectal cancer [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Jun.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on